Lianyungang, China

Yangchao Ou

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignees: Jiangsu Hengrui Medicine Company Ltd., Shanghai Hengrui Pharmaceutical, Shanghai Shengdi Pharmaceutical Co., Ltd.. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Yangchao Ou. Retrieved from https://idiyas.com/inventor/yangchao-ou

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 9.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Yangchao Ou: Innovator in Biotechnology

Introduction

Yangchao Ou is a notable inventor based in Lianyungang, China. He has made significant contributions to the field of biotechnology, particularly through his innovative work on human interleukin-2 variants.

Latest Patents

Yangchao Ou holds a patent for a "Human Interleukin-2 Variant or Derivative Thereof." This patent reflects his expertise in developing biopharmaceuticals that can potentially enhance immune responses.

Career Highlights

Throughout his career, Yangchao has worked with prominent companies in the pharmaceutical industry. He has been associated with Jiangsu Hengrui Medicine Co., Ltd. and Shanghai Hengrui Pharmaceutical, where he has contributed to various research and development projects.

Collaborations

Yangchao has collaborated with several professionals in his field, including Hongwei Wang and Qiyue Hu. These collaborations have further enriched his research and innovation efforts.

Conclusion

Yangchao Ou's work exemplifies the spirit of innovation in biotechnology, and his contributions continue to impact the industry positively. His patent and collaborations highlight his commitment to advancing medical science.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…